
Not the kind of upgrade you brag about
Credo just got the classic Wall Street “nice, but let’s not get ahead of ourselves” treatment: upgraded to Hold ahead of fiscal Q1 earnings. Translation? The business still has fans, but the stock may have outrun the story a bit.
Why the vibes are more mixed now
The bull case is still there. The note points to:
- a more attractive valuation at about 36x forward earnings
- Q1 revenue guidance of $465 million to $475 million
- expected growth of roughly 110% year over year
- improving customer concentration and solid momentum in its optical portfolio
That’s not exactly a company in the penalty box. But the party may be getting a little crowded.
The catch: growth is still good, just not as wild
The analyst’s main caution is the part investors hate hearing after a run-up: growth is decelerating and competition is heating up. When a stock is priced like a future superstar, “still growing fast” is nice, but “slowing from absurd to merely excellent” can be a problem.
Big picture
If Credo beats and raises, the stock could still get a jolt. But for now, the message is pretty simple: the easy money may have already been made, and now you’re paying premium rates for a story that’s starting to mature.
